Impact of Body Mass Index on Clinical Outcomes in Patients Undergoing Coronary Revascularization

康俊萍,马长生,吕强,聂绍平,刘新民,刘小慧,杜昕,胡荣,董建增,陈方,吕树铮,顾承雄,黄方炯,吴学思
DOI: https://doi.org/10.3969/j.issn.1004-8812.2007.03.001
2007-01-01
Abstract:Objective To determine the impact of body mass index(BMI)on clinical outcomes in patients underwent coronary revascularization.Methods The DESIRE-plus(Drug-Eluting Stent Impact on Revascularization-plus)was a single-center registry study of coronary revascularization in our institution between 1 July 2004 and 30 September 2005.We analyzed patients with complete data of BMI from the DESIRE-plus trial,grouped by BMI(low BMI group:BMI 20;normal BMI group:BMI 20-24.9;overweight group:BMI 25-29.9 and obesity group:BMI ≥30).The patients were followed up by telephone after discharge.Major adverse cerebral-cardiovascular events(MACCE)including death,neo-myocardial infarction,stroke,re-revascularization were recorded and the hazard risk for each group were then evaluated.Results A total of 2 895 patients were included in the study(92 in the low BMI group;1 106 in normal BMI group;1 454 in overweight group and 243 obesity group).Median follow-up duration was 542 days.Patients with a low BMI had an increased hazard risk(HR)for total mortality(2.711,95% CI 1.159-6.341)compared with those for patients with a normal BMI,overweight(HR 0.926,95% CI 0.541-1.588)and obese patients(HR 0.151,95% CI 0.019-1.178)who showed no increased risk for total mortality.There was hardly any significant difference in MACCE or cardiac mortality among the four groups.Conclusion There are more risk factors in coronary heart disease patients complicated with obesity or overweight,but the prognosis after revascularization of them is not inferior to the normal weight coronary heart disease patients.However,patients with a low BMI showed the worst outcome.
What problem does this paper attempt to address?